The dietary supplement L. Gasseri & SlimBiotics® is a specialized probiotic formula combining a well-researched dose of the Lactobacillus gasseri strain CNCM I-5076 with the patented probiotic blend SlimBiotics®.*
This product features a blend of well-researched probiotic strains.* Scientific studies have explored the relationship between certain microorganisms in the gut microbiota and metabolic processes.*
L. Gasseri & SlimBiotics® is part of our product category dedicated to weight management.*
Exploring the Role of Lactobacillus Gasseri and SlimBiotics® in Metabolic Support*
The supplement L. Gasseri & SlimBiotics® combines 2 probiotic strains:
- Lactobacillus gasseri, a species of lactic acid bacteria known for its role in gut microbiota balance and digestive support.* It is one of the most widely studied probiotic strains for its influence on metabolic processes.* Research in humans has explored its potential role in body composition and gut health when compared to a placebo.* Studies suggest that Lactobacillus gasseri may contribute to maintaining a balanced gut microbiota, which plays a role in overall well-being.* Research has also examined its interaction with key metabolic signals related to appetite and energy use, as well as its influence on fat metabolism pathways.* For this supplement, we have specifically selected the well-documented Lactobacillus gasseri strain CNCM I-5076.*
- SlimBiotics® is a plant-based probiotic blend, an innovative product developed and patented by the Austrian company SlimBiotics.* It consists of three strains of Lactobacillus fermentum K7-Lb1, K8-Lb1, and K11-Lb3, naturally occurring bacteria found in kimere, a fermented pearl millet porridge traditionally consumed by the Mbeere community in Kenya.* SlimBiotics® is formulated to support gut microbiota balance, and its role in metabolic health has been explored in a double-blind, randomized, placebo-controlled clinical study on individuals with specific body composition characteristics.* This unique compound has been studied for its influence on metabolic parameters in relation to probiotic supplementation.*
Three Key Features of L. Gasseri & SlimBiotics® for Metabolic Support*
Our specialized probiotic formula is distinguished by three key features:*
- Its unique combination of Lactobacillus gasseri and SlimBiotics®, featuring a well-researched blend of probiotic strains.*
- Its carefully calibrated dose, providing 12 billion CFU of Lactobacillus gasseri per day and 6 billion CFU of SlimBiotics® per day, the same amounts used in clinical research on SlimBiotics®.*
- Its gastro-resistant capsules, designed to help protect probiotics from stomach acidity during digestion, ensuring they reach the gut for optimal delivery.*
As a reminder: Research suggests that differences in gut microbiota composition may play a role in how the body processes nutrients and maintains metabolic balance.* Maintaining a diverse and balanced gut microbiota is an important factor in overall well-being.*
WARNINGS
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used as a substitute for a varied and balanced diet or a healthy lifestyle.
STORAGE
Store in a cool, dry place away from direct sunlight, heat, and humidity.
Keep out of reach of children.
PREGNANCY AND MEDICAL CONDITIONS
If you are pregnant, breastfeeding, or have any medical conditions, consult your healthcare provider before using this product.
SUPPLEMENT INTERACTIONS
Consult your healthcare provider before use, especially if you are taking any medications or other supplements as there may be potential interactions.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Daily dose: 2 capsules
Number of doses per pack: 30
| Amount per dose |
Lactobacillus gasseri CNCM I-5076
| 12x109 CFU |
SlimBiotics®
Lactobacillus fermentum K7-Lb1
Lactobacillus fermentum K8-Lb1
Lactobacillus fermentum K11-Lb3 |
6x109 CFU |
Other ingredients : acacia gum.
SlimBiotics® is a registered trademark of SlimBiotics GmbH.
|
take 2 capsules a day 30 minutes before a meal.
30 days.
- Álvarez-Arraño V, Martín-Peláez S. Effects of Probiotics and Synbiotics on … : A Systematic Review. Nutrients. 2021 Oct 17;13(10):3627. doi: 10.3390/nu13103627. PMID: 34684633; PMCID: PMC8540110.
- Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on … : A Randomized, Double-Blind Clinical Trial. Korean J Fam Med. 2013 Mar;34(2):80-9. doi: 10.4082/kjfm.2013.34.2.80. Epub 2013 Mar 20. PMID: 23560206; PMCID: PMC3611107.
- Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 Supplementation … : A Randomized, Double-Blind, Placebo-Controlled Trial. J Med Food. 2018 May;21(5):454-461. doi: 10.1089/jmf.2017.3937. Epub 2018 Apr 24. PMID: 29688793.
- Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. … Lactobacillus gasseri BNR17 in … . PLoS One. 2013;8(1):e54617. doi: 10.1371/journal.pone.0054617. Epub 2013 Jan 30. PMID: 23382926; PMCID: PMC3559800.
- https://www.nutraingredients-usa.com/Article/2023/07/10/SlimBiotics-on-plant-based-probiotic-for-...
- Laue, C.; Papazova, E.; Pannenbeckers, A.; Schrezenmeir, J. Effect of a Probiotic and a Synbiotic on … : A Human, Double-Blind, Randomised, Controlled Clinical Study. Nutrients 2023, 15, 3039. https://doi.org/10.3390/nu15133039.
- Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on … : A Randomized, Double-Blind Clinical Trial. Korean J Fam Med. 2013 Mar;34(2):80-9. doi: 10.4082/kjfm.2013.34.2.80. Epub 2013 Mar 20. PMID: 23560206; PMCID: PMC3611107.
- Miyoshi M, Ogawa A, Higurashi S, Kadooka Y. … of Lactobacillus gasseri SBT2055 accompanied by … . Eur J Nutr. 2014;53(2):599-606. doi: 10.1007/s00394-013-0568-9. Epub 2013 Aug 6. PMID: 23917447.
- de Moura E Dias M, da Silva Duarte V, Mota LFM, de Cássia Ávila Alpino G, Dos Reis Louzano SA, da Conceição LL, Mantovanie HC, Pereira SS, Oliveira LL, de Oliveira Mendes TA, Porcellato D, do Carmo Gouveia Peluzio M. 2023 Mar 3;12(5):1092. doi: 10.3390/foods12051092. PMID: 36900609; PMCID: PMC10001121.